Stay updated on DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Sign up to get notified when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now includes a related topic link (MedlinePlus Genetics) and the keyword Multiple myeloma, and the revision label was updated from v3.5.3 to v3.5.4.
    Difference
    0.2%
    Check dated 2026-05-17T10:43:14.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The study page no longer displays the condition 'Multiple Myeloma' or its related topics/resources ('related topics:' and 'MedlinePlus Genetics'). This removes expected navigational cues and context about the study's focus.
    Difference
    0.2%
    Check dated 2026-05-10T08:53:46.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page’s related-topics/link list was updated (e.g., MedlinePlus Genetics and related topics). The interface/footer revision indicator also changed from the previous version to a newer one.
    Difference
    0.2%
    Check dated 2026-04-25T18:51:03.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added a new revision label: Revision: v3.5.2. Removed related topic tags, including 'Multiple myeloma' and 'MedlinePlus Genetics', and deleted the prior revision tag 'Revision: v3.5.0'.
    Difference
    0.2%
    Check dated 2026-04-18T13:44:51.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics to the page.
    Difference
    0.2%
    Check dated 2026-04-11T10:35:29.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Removed the core disease term 'Multiple myeloma' and the related topic 'MedlinePlus Genetics' from the page. This reduces disease-specific context available to users seeking trial information on this condition.
    Difference
    0.2%
    Check dated 2026-03-28T02:58:48.000Z thumbnail image

Stay in the know with updates to DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.